Moderna (MRNA)
(Delayed Data from NSDQ)
$65.69 USD
-2.33 (-3.43%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $65.65 -0.04 (-0.06%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth D Momentum F VGM
Balance Sheet
Fiscal Year End for Moderna, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 8,604 | 9,902 | 10,727 | 4,609 | 1,104 |
Receivables | 892 | 1,385 | 3,175 | 1,391 | 5 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 202 | 949 | 1,441 | 47 | 0 |
Other Current Assets | 627 | 1,195 | 728 | 252 | 19 |
Total Current Assets | 10,325 | 13,431 | 16,071 | 6,298 | 1,129 |
Net Property & Equipment | 1,945 | 2,018 | 1,241 | 297 | 202 |
Investments & Advances | 4,677 | 8,318 | 6,843 | 639 | 160 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 81 | 982 | 326 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 685 | 988 | 46 | 13 | 13 |
Total Assets | 18,426 | 25,858 | 24,669 | 7,337 | 1,589 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 520 | 487 | 302 | 18 | 7 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,798 | 2,101 | 1,472 | 470 | 68 |
Income Taxes Payable | 63 | 48 | 876 | 0 | 0 |
Other Current Liabilities | 634 | 2,287 | 6,478 | 3,901 | 68 |
Total Current Liabilities | 3,015 | 4,923 | 9,128 | 4,389 | 143 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 83 | 673 | 615 | 177 | 139 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 575 | 912 | 599 | 110 | 39 |
Other Non-Current Liabilities | 256 | 135 | 76 | 2 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4,572 | 6,735 | 10,524 | 4,775 | 415 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 371 | 1,173 | 4,211 | 4,802 | 2,669 |
Retained Earnings | 13,606 | 18,320 | 9,958 | -2,244 | -1,496 |
Other Equity | -123 | -370 | -24 | 3 | 2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 13,854 | 19,123 | 14,145 | 2,561 | 1,175 |
Total Liabilities & Shareholder's Equity | 18,426 | 25,858 | 24,669 | 7,337 | 1,589 |
Total Common Equity | 13,854 | 19,123 | 14,145 | 2,561 | 1,175 |
Shares Outstanding | 381.20 | 384.10 | 405.40 | 395.70 | 336.50 |
Book Value Per Share | 36.34 | 49.79 | 34.89 | 6.47 | 3.49 |
Fiscal Year End for Moderna, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 8,488 | 8,523 | 8,604 | 7,573 | 8,459 |
Receivables | 163 | 137 | 892 | 1,866 | 232 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 399 | 295 | 202 | 487 | 715 |
Other Current Assets | 611 | 645 | 627 | 873 | 1,193 |
Total Current Assets | 9,661 | 9,600 | 10,325 | 10,799 | 10,599 |
Net Property & Equipment | 2,196 | 2,063 | 1,945 | 1,952 | 2,280 |
Investments & Advances | 2,326 | 3,638 | 4,677 | 5,273 | 6,105 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 81 | 81 | 81 | 0 | 1,480 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 641 | 650 | 685 | 661 | 1,290 |
Total Assets | 15,680 | 16,729 | 18,426 | 19,450 | 21,884 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 279 | 183 | 520 | 494 | 310 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,333 | 1,396 | 1,798 | 2,224 | 1,490 |
Income Taxes Payable | 7 | 52 | 63 | 56 | 47 |
Other Current Liabilities | 744 | 749 | 634 | 1,611 | 1,276 |
Total Current Liabilities | 2,363 | 2,380 | 3,015 | 4,385 | 3,123 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 95 | 58 | 83 | 166 | 692 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 576 | 575 | 575 | 575 | 843 |
Other Non-Current Liabilities | 266 | 256 | 172 | 173 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,968 | 3,912 | 4,572 | 5,995 | 4,935 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 631 | 487 | 371 | 277 | 193 |
Retained Earnings | 11,152 | 12,431 | 13,606 | 13,389 | 17,019 |
Other Equity | -71 | -101 | -123 | -211 | -263 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 11,712 | 12,817 | 13,854 | 13,455 | 16,949 |
Total Liabilities & Shareholder's Equity | 15,680 | 16,729 | 18,426 | 19,450 | 21,884 |
Total Common Equity | 11,712 | 12,817 | 13,854 | 13,455 | 16,949 |
Shares Outstanding | 384.40 | 383.20 | 381.20 | 381.20 | 381.20 |
Book Value Per Share | 30.47 | 33.45 | 36.34 | 35.30 | 44.46 |